---
title: "Honz: Wholly-owned subsidiary's ibuprofen granule product selected for national centralized procurement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277433953.md"
description: "Honz's wholly-owned subsidiary's ibuprofen granule product has been selected for the national centralized procurement, with the results to be implemented in March 2026 and ending on December 31, 2028. It is expected that the operating revenue in 2024 will be CNY 1.7355 million, accounting for 0.37% of the company's operating revenue for that year; the operating revenue for the first three quarters of 2025 is expected to be CNY 654,800, accounting for 0.20% of the operating revenue for the first three quarters. The selection will expand market sales and increase market share, positively impacting the company's future development"
datetime: "2026-03-02T09:02:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277433953.md)
  - [en](https://longbridge.com/en/news/277433953.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277433953.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/277433953.md) | [繁體中文](https://longbridge.com/zh-HK/news/277433953.md)


# Honz: Wholly-owned subsidiary's ibuprofen granule product selected for national centralized procurement

Honz announced that its wholly-owned subsidiary Hebei Kangzhi has officially been selected for the national organization procurement of ibuprofen granules, which will continue after the expiration of the procurement agreement. The selection results will be implemented in March 2026 and will end on December 31, 2028. The operating revenue of ibuprofen granules is expected to be 1.7355 million yuan in 2024, accounting for 0.37% of the company's operating revenue for that year; in the first three quarters of 2025, the operating revenue is expected to be 654,800 yuan, accounting for 0.20% of the operating revenue for the first three quarters. This selection will further expand the market sales of ibuprofen granules, increase market share, and have a positive impact on the company's future business development

### Related Stocks

- [Honz (300086.CN)](https://longbridge.com/en/quote/300086.CN.md)

## Related News & Research

- [How to approach the market during the "fog of war"](https://longbridge.com/en/news/281686621.md)
- [Earnings trend has been 'rapturous' for US companies, says Barron's editor](https://longbridge.com/en/news/281667241.md)
- [08:54 ETNew Research Claims to Show Bioavailability of Oral Liposomal Glutathione. But does it really?](https://longbridge.com/en/news/281371900.md)
- [11:33 ETFitness, Health and Wellness Experts Team Up to 'Get Fit for No Kid Hungry' with New On-Demand Initiative](https://longbridge.com/en/news/281213207.md)
- [Former NASA administrator cals Artemis II mission a ‘baby step’ to Mars](https://longbridge.com/en/news/281656889.md)